Case report: five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome.

Ours, Christopher A; Sapp, Julie C; Hodges, Mia B; de Moya, Allison J; Biesecker, Leslie G

Ours, Christopher A; Sapp, Julie C; Hodges, Mia B; de Moya, Allison J; Biesecker, Leslie G.

Afiliação

Ours CA; Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Sapp JC; Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Hodges MB; Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
de Moya AJ; Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Biesecker LG; Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Cold Spring Harb Mol Case Stud ; 7(6)2021 12.

Article em En | MEDLINE | ID: mdl-34649967

Assuntos

Síndrome de Proteu; Proteínas Proto-Oncogênicas c-akt; Aminopiridinas; Humanos; Imidazóis; Masculino

Palavras-chave

bone pain; connective tissue nevi; multiple skeletal anomalies; overgrowth

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Proteu / Proteínas Proto-Oncogênicas c-akt Limite: Humans / Male Idioma: En Revista: Cold Spring Harb Mol Case Stud Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google